Interleukin 1 inhibition with anakinra in adult-onset Still disease: a meta-analysis of its efficacy and safety

References

• Kontzias A Efthimiou P Adult-onset Still’s disease: pathogenesis, clinical manifestations and therapeutic advances Drugs 2008 68 3 319 337 18257609
   PubMed Web of Science ®Google Scholar
• Gerfaud-Valentin M Jamilloux Y Iwaz J Seve P Adult-onset Still’s disease Autoimmun Rev 2014 13 7 708 722 24657513
   PubMed Web of Science ®Google Scholar
• Efthimiou P Paik PK Bielory L Diagnosis and management of adult onset Still’s disease Ann Rheum Dis 2006 65 5 564 572 16219707
   PubMed Web of Science ®Google Scholar
• Pay S Türkçapar N Kalyoncu M Ankara Rheumatology Study Group A multicenter study of patients with adult-onset Still’s disease compared with systemic juvenile idiopathic arthritis Clin Rheumatol 2006 25 5 639 644 16365690
   PubMed Web of Science ®Google Scholar
• Franchini S Dagna L Salvo F Aiello P Baldissera E Sabbadini MG Efficacy of traditional and biologic agents in different clinical phenotypes of adult-onset Still’s disease Arthritis Rheum 2010 62 8 2530 2535 20506370
   PubMed Web of Science ®Google Scholar
• Kim HA Sung JM Suh CH Therapeutic responses and prognosis in adult-onset Still’s disease Rheumatol Int 2012 32 5 1291 1298 21274538
   PubMed Web of Science ®Google Scholar
• Krzossok S Benck U van der Woude FJ Braun C Disseminated intravascular coagulation, perimyocarditis and bilateral pleural empyema in adult Still’s disease Dtsch Med Wochenschr 2004 129 47 2535 2537 German 15543470
   PubMed Web of Science ®Google Scholar
• Hot A Toh ML Coppéré B Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features and long-term outcome: a case-control study of 8 patients Medicine (Baltimore) 2010 89 1 37 46 20075703
   PubMed Web of Science ®Google Scholar
• Fautrel B Borget C Rozenberg S Corticosteroid sparing effect of low dose methotrexate treatment in adult Still’s disease J Rheumatol 1999 26 2 373 378 9972972
   PubMed Web of Science ®Google Scholar
• Nagashima T Iwamoto M Matsumoto K Minota S Interleukin-18 in adult-onset Still’s disease: treatment target or disease activity indicator? Intern Med 2012 51 4 449 author reply 451 22333388
   PubMed Web of Science ®Google Scholar
• Kato T Kobayashi T Nishino H Hidaka Y Double-filtration plasmapheresis for resolution of corticosteroid resistant adult onset Still’s disease Clin Rheumatol 2006 25 4 579 582 16568213
   PubMed Web of Science ®Google Scholar
• Yip CMS Lee TL Chan HB Lau YL Macrophage activation syndrome after initiation of corticosteroid and etanercept in a patient with adult onset Still’s disease HK J Paediatr 2008 13 3 174 179
   Google Scholar
• Gerfaud-Valentin M Maucort-Boulch D Hot A Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients Medicine (Baltimore) 2014 93 2 91 99 24646465
   PubMed Web of Science ®Google Scholar
• Kötter I Wacker A Koch S Anakinra in patients with treatment-resistant adult-onset Still’s disease: four case reports with serial cytokine measurements and a review of the literature Semin Arthritis Rheum 2007 37 3 189 197 17583775
   PubMed Web of Science ®Google Scholar
• Raffeiner B Botsios C Dinarello C Ometto F Punzi L Ramonda R Adult-onset Still’s disease with myocarditis successfully treated with the interleukin-1 receptor antagonist anakinra Joint Bone Spine 2011 78 1 100 101 21036649
   PubMed Web of Science ®Google Scholar
• Hoshino T Ohta A Yang D Elevated serum interleukin 6, interferon-gamma, and tumor necrosis factor-alpha levels in patients with adult Still’s disease J Rheumatol 1998 25 2 396 398 9489848
   PubMed Web of Science ®Google Scholar
• Giampietro C Fautrel B Anti-interleukin-1 agents in adult onset Still’s disease Int J Inflam 2012 2012 317820 22611515
   PubMedGoogle Scholar
• Rudinskaya A Trock DH Successful treatment of a patient with refractory adult-onset still disease with anakinra J Clin Rheumatol 2003 9 5 330 332 17041487
   PubMed Web of Science ®Google Scholar
• Fleischmann RM Schechtman J Bennett R Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-controlled trial Arthritis Rheum 2003 48 4 927 934 12687534
   PubMed Web of Science ®Google Scholar
• Kalliolias GD Georgiou PE Antonopoulos IA Andonopoulos AP Liossis SN Anakinra treatment in patients with adult-onset Still’s disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial Ann Rheum Dis 2007 66 6 842 843 17513574
   PubMed Web of Science ®Google Scholar
• Cush JJ Medsger TA Christy WC Herbert DC Cooperstein LA Adult-onset Still’s disease. Clinical course and outcome Arthritis Rheum 1987 30 2 186 194 3827959
   PubMed Web of Science ®Google Scholar
• Yamaguchi M Ohta A Tsunematsu T Preliminary criteria for classification of adult Still’s disease J Rheumatol 1992 19 3 424 430 1578458
   PubMed Web of Science ®Google Scholar
• Fautrel B Zing E Golmard JL Proposal for a new set of classification criteria for adult-onset still disease Medicine (Baltimore) 2002 81 3 194 200 11997716
   PubMed Web of Science ®Google Scholar
• Singal AK Fontana RJ Meta-analysis: oral anti-viral agents in adults with decompensated hepatitis B virus cirrhosis Aliment Pharmacol Ther 2012 35 6 674 689 22257108
   PubMed Web of Science ®Google Scholar
• Singal AK Salameh H Kuo YF Fontana RJ Meta-analysis: the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B Aliment Pharmacol Ther 2013 38 2 98 106 23713520
   PubMed Web of Science ®Google Scholar
• Zintzaras E Ioannidis JP Heterogeneity testing in meta-analysis of genome searches Genet Epidemiol 2005 28 2 123 137 15593093
   PubMed Web of Science ®Google Scholar
• Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 Oxford The Cochrane Collaboration 2011 [updated March 2011]. Available from: www.cochrane-handbook.org Accessed October 8, 2014
   Google Scholar
• Lequerré T Quartier P Rosellini D Société Francophone pour la Rhumatologie et les Maladies Inflammatoires en Pédiatrie (SOFREMIP) Club Rhumatismes et Inflammation (CRI) Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France Ann Rheum Dis 2008 67 3 302 308 17947302
   PubMed Web of Science ®Google Scholar
• Nordström D Knight A Luukkainen R Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still’s disease. An open, randomized, multicenter study J Rheumatol 2012 39 10 2008 2011 22859346
   PubMed Web of Science ®Google Scholar
• Cavalli G Franchini S Berti A Efficacy and safety of biologic agents in adult-onset Still’s disease: A long-term follow-up of 19 patients at a single referral center [abstract] Arthritis Rheum 2013 65 Suppl 10 S2028
   Google Scholar
• Giampietro C Ridene M Lequerre T CRI (Club Rhumatismes et Inflammation) Anakinra in adult-onset Still’s disease: long-term treatment in patients resistant to conventional therapy Arthritis Care Res (Hoboken) 2013 65 5 822 826 23225779
   PubMed Web of Science ®Google Scholar
• Laskari K Tzioufas AG Moutsopoulos HM Efficacy and long-term follow-up of IL-1R inhibitor anakinra in adults with Still’s disease: a case-series study Arthritis Res Ther 2011 13 3 R91 21682863
   PubMed Web of Science ®Google Scholar
• Iliou C Papagoras C Tsifetaki N Voulgari PV Drosos AA Adult-onset Still’s disease: clinical, serological and therapeutic considerations Clin Exp Rheumatol 2013 31 1 47 52 23010097
   PubMed Web of Science ®Google Scholar
• Giampietro C Ridene M Fautrel B Bourgeois P Long term treatment with anakinra in patients with adult-onset Still disease [abstract] Arthritis Rheum 2010 62 Suppl 10 S902
   Google Scholar
• Moher D Liberati A Tetzlaff J Altman DG PRISMA Group Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement J Clin Epidemiol 2009 62 10 1006 1012 19631508
   PubMed Web of Science ®Google Scholar
• Magadur-Joly G Billaud E Barrier JH Epidemiology of adult Still’s disease: estimate of the incidence by a retrospective study in west France Ann Rheum Dis 1995 54 7 587 590 7668903
   PubMed Web of Science ®Google Scholar
• Choi JH Suh CH Lee YM Serum cytokine profiles in patients with adult onset Still’s disease J Rheumatol 2003 30 11 2422 2427 14677188
   PubMed Web of Science ®Google Scholar
• Chen DY Lan JL Lin FJ Hsieh TY Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still’s disease J Rheumatol 2004 31 11 2189 2198 15517632
   PubMed Web of Science ®Google Scholar
• Fautrel B Adult-onset Still disease Best Pract Res Clin Rheumatol 2008 22 5 773 792 19028363
   PubMed Web of Science ®Google Scholar
• Sekkach Y Elqatni M Khattabi AE Antagonists of interleukin-6 (tocilizumab), in adult refractory still disease Presse Med 2011 40 7–8 e333 e337 French 21550202
   PubMedGoogle Scholar
• Rech J Ronneberger M Englbrecht M Successful treatment of adult-onset Still’s disease refractory to TNF and IL-1 blockade by IL-6 receptor blockade Ann Rheum Dis 2011 70 2 390 392 20650873
   PubMed Web of Science ®Google Scholar
• Tsakiri N Kimber I Rothwell NJ Pinteaux E Interleukin-1-induced interleukin-6 synthesis is mediated by the neutral sphingomyelinase/Src kinase pathway in neurones Br J Pharmacol 2008 153 4 775 783 18059318
   PubMed Web of Science ®Google Scholar
• Kim YJ Koo BS Kim YG Lee CK Yoo B Clinical features and prognosis in 82 patients with adult-onset Still’s disease Clin Exp Rheumatol 2014 32 1 28 33 24050706
   PubMed Web of Science ®Google Scholar
• Kong XD Xu D Zhang W Zhao Y Zeng X Zhang F Clinical features and prognosis in adult-onset Still’s disease: a study of 104 cases Clin Rheumatol 2010 29 9 1015 1019 20549276
   PubMed Web of Science ®Google Scholar
• Jung KH Kim JJ Lee JS Interleukin-18 as an efficient marker for remission and follow-up in patients with inactive adult-onset Still’s disease Scand J Rheumatol 2014 43 2 162 169 24134323
   PubMed Web of Science ®Google Scholar
• Fujii T Akizuki M Kameda H Methotrexate treatment in patients with adult onset Still’s disease – retrospective study of 13 Japanese cases Ann Rheum Dis 1997 56 2 144 148 9068291
   PubMed Web of Science ®Google Scholar
• Ghosal A Pal RB Das SK Das T An unusual presentation of adult onset Still’s disease Med J Malaysia 2012 67 5 532 533 23770876
   PubMedGoogle Scholar
• Lim E Chng HH Adult-onset Still’s disease in an oriental population: manifestations, course and outcome in 16 patients Ann Acad Med Singapore 1998 27 1 11 15 9588268
   PubMedGoogle Scholar
• Yeh HM Liu MF Chang KK Liu SM Chen CH Adult-onset Still’s disease complicated with hemophagocytic syndrome J Formos Med Assoc 2010 109 1 85 88 20123591
   PubMed Web of Science ®Google Scholar
• Scholtze D Varga Z Imhof A Post-infection immunocomplex glomerulonephritis and Legionnaires’ disease in a patient with adult Still’s disease during treatment with interleukin 1 receptor antagonist anakinra: a case report J Med Case Rep 2011 5 299 21740588
   PubMedGoogle Scholar
• Izumikawa K Morinaga Y Kondo A Adult Still’s disease associated with cytomegalovirus infection J Infect Chemother 2007 13 2 114 117 17458680
   PubMedGoogle Scholar
• Puéchal X DeBandt M Berthelot JM Club Rhumatismes Et Inflammation Tocilizumab in refractory adult Still’s disease Arthritis Care Res (Hoboken) 2011 63 1 155 159 20740616
   PubMed Web of Science ®Google Scholar
• Hu Q Yan Z Zhong J Adult-onset Still’s disease: how to make a diagnosis in an atypical case Rheumatol Int 2012 32 10 3299 3302 21877245
   PubMed Web of Science ®Google Scholar
• Menge F Schacherer C Wigand R Brodt R Caspary WF Stein J Adult-onset Still’s disease. Differential diagnosis in recurrent pharyngitis, fever of unknown original and excessive hyperferritinemia Dtsch Med Wochenschr 1999 124 27 829 832 German 10432943
   PubMed Web of Science ®Google Scholar
• Zeng T Zou YQ Wu MF Yang CD Clinical features and prognosis of adult-onset still’s disease: 61 cases from China J Rheumatol 2009 36 5 1026 1031 19273456
   PubMed Web of Science ®Google Scholar
• Ohta A Yamaguchi M Tsunematsu T Adult Still’s disease: a multicenter survey of Japanese patients J Rheumatol 1990 17 8 1058 1063 2213780
   PubMed Web of Science ®Google Scholar
• Michel M Hayem G Rat AC Fatal infectious complications in 2 patients with adult onset Still disease Rev Med Interne 1996 17 5 407 409 French 8763101
   PubMed Web of Science ®Google Scholar
• Assimakopoulos SF Karamouzos V Papakonstantinou C Zolota V Labropoulou-Karatza C Gogos C Granulomas formation in lymph nodes, liver and spleen in adult-onset Still’s disease: A case report J Clin Med Res 2013 5 2 144 149 23519167
   PubMedGoogle Scholar
• Assimakopoulos SF Karamouzos V Papakonstantinou C Zolota V Labropoulou-Karatza C Gogos C Suppurative necrotizing granulomatous lymphadenitis in adult-onset Still’s disease: a case report J Med Case Rep 2012 6 354 23078628
   PubMedGoogle Scholar
• Guignard S Dien G Dougados M Severe systemic inflammatory response syndrome in a patient with adult onset Still’s disease treated with the anti-IL1 drug anakinra: a case report Clin Exp Rheumatol 2007 25 5 758 759 18078628
   PubMed Web of Science ®Google Scholar